Operating Lease, Right-of-Use Asset of Enveric Biosciences, Inc. from 02 Jan 2019 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Enveric Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Jan 2019 to 30 Jun 2023.
  • Enveric Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2023 was $9,607, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Enveric Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $9,607 -$111,360 -92% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $37,041 -$114,276 -76% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $63,817 -$112,487 -64% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $88,768 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $120,967 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $151,317 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $176,304 31 Dec 2021 10-K/A 09 Jun 2023 2022 FY
Q3 2020 $874,606 +$559,419 +177% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $906,995 +$563,280 +164% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q4 2019 $286,163 -$85,591 -23% 31 Dec 2019 10-Q 16 Nov 2020 2020 Q3
Q3 2019 $315,187 30 Sep 2019 10-K/A 12 Aug 2020 2019 FY
Q2 2019 $343,715 30 Jun 2019 10-K/A 12 Aug 2020 2019 FY
Q4 2018 $371,754 02 Jan 2019 10-K/A 12 Aug 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.